Doctors prescribing fewer antipsychotics for seniors after FDA warnings

Share this article:
Since the U.S. Food and Drug Administration put “black box” warnings on certain antipsychotics for seniors with dementia, doctors have been prescribing less of them, a new study found.

Researchers using data from Veterans Affairs registries found that overall use of older and newer antipsychotics dropped from 18% in 1999 to 12% in 2007, according to Reuters. Short of pulling it from the market, putting a black box warning on it is the strongest signal the FDA can send regarding the risks of a drug. Doctors in long-term care settings have been using drugs such as Seroquel and Risperdal with dementia patients exhibiting paranoia, aggression and agitation.

Researcher Dr. Helen C. Kales, a psychiatrist at the University of Michigan, said these drugs can still be beneficial to some patients, but added that simple changes, such as switching a patient from a female caregiver to a male caregiver, can ease symptoms, too. The study was published in the Feb. 7 issue of the Archives of General Psychology.
Share this article:

More in News

Large hepatitis outbreak reaches 47 cases, podiatry company denies ManorCare's charges

The number of people infected in an infamous North Dakota Hepatitis C outbreak has risen, state health officials say.

National Quality Forum supports quality measures in bill to standardize post-acute assessments

National Quality Forum supports quality measures in bill ...

The National Quality Forum has come out in strong support of a proposed standardized quality measures, such as skin integrity, across different types of post-acute care settings. Uniform assessments are ...

CMS changes mind on hospice drugs

The Centers for Medicaid & Medicare Services has revised guidance on authorization of hospice drugs for those under Medicare Advantage and Part D plans, according to a new memo.